ADIPOQ and neoplasm: Adiponectin treatment significantly attenuated phosphorylations of Akt and GSK3beta and beta-catenin protein levels and nuclear activities, as well as inhibited cell proliferation to a greater extent in PyVT (+/−)/ADN(+/−) tumor cells (Figure 8).